Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | STTK |
---|---|---|
09:32 ET | 366 | 7.55 |
09:36 ET | 1101 | 7.485 |
09:38 ET | 900 | 7.57 |
09:41 ET | 1300 | 7.46 |
09:43 ET | 459 | 7.45 |
09:45 ET | 600 | 7.41 |
09:48 ET | 1400 | 7.37 |
09:50 ET | 4569 | 7.405 |
09:57 ET | 1200 | 7.35 |
10:03 ET | 100 | 7.34 |
10:08 ET | 100 | 7.34 |
10:10 ET | 300 | 7.34 |
10:12 ET | 200 | 7.34 |
10:14 ET | 200 | 7.34 |
10:15 ET | 100 | 7.34 |
10:17 ET | 1200 | 7.43 |
10:21 ET | 200 | 7.43 |
10:35 ET | 400 | 7.4 |
10:42 ET | 100 | 7.34 |
10:44 ET | 200 | 7.34 |
10:46 ET | 904 | 7.38 |
10:50 ET | 700 | 7.35 |
10:53 ET | 366 | 7.35 |
11:13 ET | 1200 | 7.4 |
11:18 ET | 333 | 7.42 |
11:22 ET | 100 | 7.44 |
11:24 ET | 200 | 7.44 |
11:26 ET | 409 | 7.45 |
11:27 ET | 300 | 7.45 |
11:31 ET | 200 | 7.47 |
11:33 ET | 200 | 7.46 |
11:36 ET | 700 | 7.43 |
11:44 ET | 1200 | 7.46 |
11:45 ET | 400 | 7.46 |
11:51 ET | 100 | 7.46 |
11:56 ET | 200 | 7.45 |
12:02 ET | 400 | 7.45 |
12:05 ET | 300 | 7.43 |
12:21 ET | 1028 | 7.43 |
12:27 ET | 500 | 7.47 |
12:30 ET | 356 | 7.47 |
12:32 ET | 4636 | 7.49 |
12:34 ET | 3390 | 7.41 |
12:36 ET | 465 | 7.435 |
12:45 ET | 159 | 7.41 |
12:48 ET | 1505 | 7.405 |
12:50 ET | 1209 | 7.35 |
12:52 ET | 871 | 7.37 |
01:10 ET | 683 | 7.38 |
01:12 ET | 100 | 7.37 |
01:17 ET | 100 | 7.39 |
01:24 ET | 1324 | 7.36 |
01:26 ET | 958 | 7.37 |
01:32 ET | 500 | 7.41 |
01:37 ET | 2179 | 7.42 |
01:39 ET | 200 | 7.42 |
01:42 ET | 100 | 7.42 |
01:46 ET | 100 | 7.43 |
01:53 ET | 100 | 7.43 |
01:57 ET | 100 | 7.42 |
02:02 ET | 100 | 7.43 |
02:08 ET | 1532 | 7.44 |
02:09 ET | 6894 | 7.48 |
02:11 ET | 6326 | 7.46 |
02:18 ET | 1152 | 7.46 |
02:20 ET | 200 | 7.44 |
02:22 ET | 500 | 7.42 |
02:29 ET | 1029 | 7.425 |
02:31 ET | 500 | 7.41 |
02:33 ET | 383 | 7.4 |
02:36 ET | 100 | 7.4 |
02:44 ET | 100 | 7.4 |
02:45 ET | 900 | 7.41 |
02:47 ET | 300 | 7.44 |
02:49 ET | 200 | 7.42 |
02:51 ET | 100 | 7.43 |
02:54 ET | 100 | 7.43 |
02:56 ET | 573 | 7.44 |
02:58 ET | 522 | 7.445 |
03:02 ET | 1394 | 7.425 |
03:03 ET | 1380 | 7.4 |
03:05 ET | 313 | 7.395 |
03:09 ET | 100 | 7.41 |
03:12 ET | 764 | 7.41 |
03:14 ET | 1944 | 7.4125 |
03:16 ET | 400 | 7.39 |
03:18 ET | 100 | 7.38 |
03:20 ET | 200 | 7.38 |
03:21 ET | 300 | 7.37 |
03:23 ET | 1320 | 7.395 |
03:25 ET | 300 | 7.39 |
03:27 ET | 1327 | 7.37 |
03:30 ET | 1937 | 7.34 |
03:32 ET | 231 | 7.33 |
03:34 ET | 161 | 7.33 |
03:36 ET | 1457 | 7.35 |
03:38 ET | 200 | 7.35 |
03:39 ET | 1355 | 7.35 |
03:41 ET | 846 | 7.35 |
03:43 ET | 518 | 7.335 |
03:45 ET | 2451 | 7.35 |
03:48 ET | 1550 | 7.32 |
03:50 ET | 1094 | 7.305 |
03:52 ET | 7811 | 7.39 |
03:54 ET | 3187 | 7.37 |
03:56 ET | 2130 | 7.355 |
03:57 ET | 3448 | 7.33 |
03:59 ET | 3757 | 7.38 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Shattuck Labs Inc | 350.9M | -3.8x | --- |
Tourmaline Bio Inc | 353.2M | -2.6x | --- |
Anavex Life Sciences Corp | 343.6M | -8.2x | --- |
Nautilus Biotechnology Inc | 343.2M | -5.1x | --- |
Aura Biosciences Inc | 364.1M | -3.9x | --- |
Ventyx Biosciences Inc | 337.0M | -1.5x | --- |
Shattuck Labs, Inc. is a clinical-stage biotechnology company. The Company is engaged in the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the CD47/SIRPa macrophage checkpoint interaction and activate the CD40 costimulatory receptor to induce an antitumor immune response. It is conducting a Phase IA/B clinical trial in patients with acute myeloid leukemia (AML) and HR-MDS. It has completed the Phase IA dose-escalation portion of this clinical trial and are enrolling patients in the Phase IB expansion cohorts evaluating SL-172154 in combination with azacitidine in frontline HR-MDS or frontline TP53 mutant (TP53m) AML. It has developed the ARC platform to address the need for a single therapeutic that consolidates multiple immune functions.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $350.9M |
---|---|
Revenue (TTM) | $2.7M |
Shares Outstanding | 47.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.86 |
EPS | $-1.93 |
Book Value | $3.06 |
P/E Ratio | -3.8x |
Price/Sales (TTM) | 129.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,327.44% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.